product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
BACH2 (D3T3G) Rabbit mAb
catalog :
80775
clonality :
monoclonal
host :
domestic rabbit
conjugate :
nonconjugated
clone name :
D3T3G
reactivity :
human
application :
western blot
more info or order :
Cell Signaling Technology product webpage
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; fig 5
Chi V, Garaud S, De Silva P, Thibaud V, Stamatopoulos B, Berehad M, et al. Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC Cancer. 2019;19:81 pubmed publisher
Chauss D, Freiwald T, McGregor R, Yan B, Wang L, Nova Lamperti E, et al. Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells. Nat Immunol. 2022;23:62-74 pubmed publisher
Do J, Zwick D, Kenyon J, Zhong F, Askew D, Huang A, et al. Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability. Sci Rep. 2021;11:10676 pubmed publisher
Richter A, Sender S, Lenz A, Schwarz R, Hinz B, Knuebel G, et al. Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo. BMC Cancer. 2020;20:184 pubmed publisher
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.